Polyamine Biomarkers of Parkinson's Disease Progression

被引：0
|
作者：
LeWitt, P. A. [1 ,2 ]
Hong, L. [1 ]
Patil, R. [3 ]
机构：
[1] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA
[2] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA
[3] Univ Cent Florida, Sch Med, Orlando, FL USA
[4] Univ Rochester, Rochester, NY USA
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [21] The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
    B. R. Bloem
    W. J. Marks
    A. L. Silva de Lima
    M. L. Kuijf
    T. van Laar
    B. P. F. Jacobs
    M. M. Verbeek
    R. C. Helmich
    B. P. van de Warrenburg
    L. J. W. Evers
    J. intHout
    T. van de Zande
    T. M. Snyder
    R. Kapur
    M. J. Meinders
    BMC Neurology, 19
  • [22] CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Ju-Hee Kang
    Brit Mollenhauer
    Christopher S. Coffey
    Jon B. Toledo
    Daniel Weintraub
    Douglas R. Galasko
    David J. Irwin
    Vivianna Van Deerlin
    Alice S. Chen-Plotkin
    Chelsea Caspell-Garcia
    Teresa Waligórska
    Peggy Taylor
    Nirali Shah
    Sarah Pan
    Pawel Zero
    Mark Frasier
    Kenneth Marek
    Karl Kieburtz
    Danna Jennings
    Caroline M. Tanner
    Tanya Simuni
    Andrew Singleton
    Arthur W. Toga
    Sohini Chowdhury
    John Q. Trojanowski
    Leslie M. Shaw
    Acta Neuropathologica, 2016, 131 : 935 - 949
  • [23] CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
    Kang, Ju-Hee
    Mollenhauer, Brit
    Coffey, Christopher S.
    Toledo, Jon B.
    Weintraub, Daniel
    Galasko, Douglas R.
    Irwin, David J.
    Van Deerlin, Vivianna
    Chen-Plotkin, Alice S.
    Caspell-Garcia, Chelsea
    Waligorska, Teresa
    Taylor, Peggy
    Shah, Nirali
    Pan, Sarah
    Zero, Pawel
    Frasier, Mark
    Marek, Kenneth
    Kieburtz, Karl
    Jennings, Danna
    Tanner, Caroline M.
    Simuni, Tanya
    Singleton, Andrew
    Toga, Arthur W.
    Chowdhury, Sohini
    Trojanowski, John Q.
    Shaw, Leslie M.
    ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 935 - 949
  • [24] CSF biomarkers and clinical progression of Parkinson disease
    Hall, Sara
    Surova, Yulia
    Ohrfelt, Annika
    Zetterberg, Henrik
    Lindqvist, Daniel
    Hansson, Oskar
    NEUROLOGY, 2015, 84 (01) : 57 - 63
  • [25] Identifying biomarkers to predict disease progression in early stage Parkinson's disease patients
    Neilson, L.
    Baird, J.
    Lobb, B.
    Vanderjagt, H.
    Gray, N.
    O'Connor, S.
    Quinn, J.
    MOVEMENT DISORDERS, 2020, 35 : S368 - S369
  • [26] Biomarkers for Parkinson's Disease
    Sherer, Todd B.
    SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (79)
  • [27] Biomarkers and Parkinson's disease
    Michell, AW
    Lewis, SJG
    Foltynie, T
    Barker, RA
    BRAIN, 2004, 127 : 1693 - 1705
  • [28] Biomarkers in Parkinson's Disease
    Morgan, John C.
    Mehta, Shyamal H.
    Sethi, Kapil D.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2010, 10 (06) : 423 - 430
  • [29] Biomarkers in Parkinson’s Disease
    John C. Morgan
    Shyamal H. Mehta
    Kapil D. Sethi
    Current Neurology and Neuroscience Reports, 2010, 10 : 423 - 430
  • [30] BIOMARKERS OF PARKINSON'S DISEASE
    Kondybayeva, A.
    Aralbayeva, A.
    Kamenova, S.
    Akimniyazova, A.
    Pyrkova, A.
    Ivashchenko, A.
    Kuzhybayeva, K.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 27 - 27
12345